“…Similarly, in other studies, use of intranasal steroid in both children and adults was also low, ranging from 11 to 26%. 25,[30][31][32][33] One largescale U.S. survey found that 24% of children took no AR medication at all. 32 While patient adherence may play a role in our sample, the impact was likely minimal given that only 33% received appropriate AR treatment.…”
Section: Ar Treatment Deserves Emphasis In Urban Areasmentioning
Allergic rhinitis (AR) is a risk factor for the development of asthma, and if poorly controlled, it may exacerbate asthma. We sought to describe AR symptoms and treatment in a larger study about asthma, sleep, and school performance. We examined the proportion (1) who met criteria for AR in an urban sample of school children with persistent asthma symptoms, (2) whose caregivers stated that they were not told of their child's allergies, (3) who had AR but were not treated or were undertreated for the disease, as well as (4) caregivers and healthcare providers' perceptions of the child's allergy status compared with study assessment, and (5) associations between self-report of asthma and AR control over a 4-week monitoring period. One hundred sixty-six children with persistent asthma participated in a clinical evaluation of asthma and rhinitis, including allergy testing. Self-report of asthma control and rhinitis control using the Childhood Asthma Control Test (C-ACT) and Rhinitis Control Assessment Test (RCAT) were measured 1 month after the study clinic session. Persistent rhinitis symptoms were reported by 72% of participants; 54% of rhinitis symptoms were moderate in severity, though only 33% of the sample received adequate treatment. AR was newly diagnosed for 53% during the clinic evaluation. Only 15% reported using intranasal steroids. Participants with poorly controlled AR had poorer asthma control compared with those with well-controlled AR. This sample of urban school-aged children with persistent asthma had underdiagnosed and undertreated AR. Healthcare providers and caregivers in urban settings need additional education about the role of allergies in asthma, recognition of AR symptoms, and AR's essential function in the comanagement of asthma. Barriers to linkages with allergy specialists need to be identified.
“…Similarly, in other studies, use of intranasal steroid in both children and adults was also low, ranging from 11 to 26%. 25,[30][31][32][33] One largescale U.S. survey found that 24% of children took no AR medication at all. 32 While patient adherence may play a role in our sample, the impact was likely minimal given that only 33% received appropriate AR treatment.…”
Section: Ar Treatment Deserves Emphasis In Urban Areasmentioning
Allergic rhinitis (AR) is a risk factor for the development of asthma, and if poorly controlled, it may exacerbate asthma. We sought to describe AR symptoms and treatment in a larger study about asthma, sleep, and school performance. We examined the proportion (1) who met criteria for AR in an urban sample of school children with persistent asthma symptoms, (2) whose caregivers stated that they were not told of their child's allergies, (3) who had AR but were not treated or were undertreated for the disease, as well as (4) caregivers and healthcare providers' perceptions of the child's allergy status compared with study assessment, and (5) associations between self-report of asthma and AR control over a 4-week monitoring period. One hundred sixty-six children with persistent asthma participated in a clinical evaluation of asthma and rhinitis, including allergy testing. Self-report of asthma control and rhinitis control using the Childhood Asthma Control Test (C-ACT) and Rhinitis Control Assessment Test (RCAT) were measured 1 month after the study clinic session. Persistent rhinitis symptoms were reported by 72% of participants; 54% of rhinitis symptoms were moderate in severity, though only 33% of the sample received adequate treatment. AR was newly diagnosed for 53% during the clinic evaluation. Only 15% reported using intranasal steroids. Participants with poorly controlled AR had poorer asthma control compared with those with well-controlled AR. This sample of urban school-aged children with persistent asthma had underdiagnosed and undertreated AR. Healthcare providers and caregivers in urban settings need additional education about the role of allergies in asthma, recognition of AR symptoms, and AR's essential function in the comanagement of asthma. Barriers to linkages with allergy specialists need to be identified.
“…SDB is well documented to occur in children and adolescents with AR (5,11) The most common symptom is nasal obstruction. In children there are typical appearances associated with AR including mouth breathing, allergic shiners, allergic crease, allergic facies and these may be reversed by treatment of the rhinitis.…”
“…1 Approximately 40% of children with AR carry a concurrent diagnosis of asthma and 60 to 80% of children with asthma may have AR. [2][3][4][5] In addition to the direct impact on a child's health and quality of life, 2,6 AR is associated with poorly controlled asthma in children. [7][8][9] Asthma exacerbations and asthma-related emergency department (ED) visits also are associated with AR 10 and treatment of AR in individuals with asthma is associated with reductions in asthmarelated hospital admissions and ED visits.…”
Background-Although mouse and cockroach allergy are known to be important in urban children with asthma, the independent association of mouse and cockroach sensitization with rhinitis in these children is unknown.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.